Co-Diagnostics JV leases manufacturing facility in Saudi Arabia
CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City
CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City
The upgraded Rajajipuram centre now features enhanced retina services and advanced OCT technology
The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
The US regulator conducted an inspection at the Amaliya manufacturing plant between April 20 and May 1, 2026
The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
Subscribe To Our Newsletter & Stay Updated